Key result
Despite longer survival and robust LDL-C reduction, 70% of Japanese patients with homozygous familial hypercholesterolemia in a contemporary registry had suffered coronary events.
Answers are grounded in this paper and cite their sources.
Contemporary registries show that while HoFH patients are living longer due to advanced lipid-lowering therapies, they still face a paradoxically high burden of premature atherosclerotic cardiovascular and valvular disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2023) conducted an editorial in Homozygous familial hypercholesterolemia (n=201). Homozygous familial hypercholesterolemia was evaluated on Coronary events. Despite longer survival and robust LDL-C reduction, 70% of Japanese patients with homozygous familial hypercholesterolemia in a contemporary registry had suffered coronary events.
Synapse has enriched 10 related papers. Consider them for comparative context: